RNAC Cartesian Therapeutics, Inc.
Nasdaq · SEC CIK 1453687 · EDGAR
- Bought, last 12 months
- $205.8K 1 purchases by 1 insiders
- Sold, last 12 months
- $258.7K 3 sales by 3 insiders
- Filings on record
- 182 since 2021-07-09, latest 2026-04-06 16:28
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BARABE TIMOTHY C | Dir | $205.8K | — |
| Brunn Carsten | Pres, CEO, Dir | — | $162.1K |
| Davis Blaine | CFO | — | $72.2K |
| Miljkovic Milos | Chief Medical Off | — | $24.4K |
| Bot Adrian Ion | Dir | — | — |
| Seymour June Ann | CAO | — | — |
| English Emily | Chief Ops Off | — | — |
| Hoge Elizabeth | 10% | — | — |
| Singer Michael | Dir | — | — |
| Kalayoglu Murat | Dir, 10% | — | — |
Transactions 169
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-04 | 2024-01-02 | RNAC | Davis Blaine | CFO | A - Grant | $0.00 | +2.42M | 2.42M | New | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | Jewell Christopher M | CSO | A - Grant | $0.00 | +778.2K | 778.2K | New | $0 |
| DMI | 2023-11-15 | 2023-11-13 | RNAC | Singer Michael | Dir, 10% | J - Other | $0.00 | +337.3K | 7,616 | New | $0 |
| D | 2023-11-15 | 2023-11-13 | RNAC | Singer Michael | Dir, 10% | A - Grant | $0.00 | +110.1K | 110.1K | New | $0 |
| D | 2023-11-15 | 2023-11-13 | RNAC | Kalayoglu Murat | Dir, 10% | A - Grant | $0.00 | +257.7K | 257.7K | New | $0 |
| DI | 2023-11-15 | 2023-11-13 | RNAC | Kalayoglu Murat | Dir, 10% | J - Other | $0.00 | +3.30M | 3.30M | New | $0 |
| DM | 2023-11-15 | 2023-11-13 | RNAC | Brunn Carsten | Pres, CEO, Dir | D - Sale to Iss | $2.06 | -521.1K | 544.8K | -49% | -$1.07M |
| DI | 2023-11-15 | 2023-11-15 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $403.47 | +24.8K | 24.8K | New | +$10.00M |
| D | 2023-11-15 | 2023-11-15 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | A - Grant | $403.47 | +123.9K | 123.9K | New | +$50.00M |
| 2023-09-26 | 2023-09-25 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.06 | -2,932 | 783.1K | -0.4% | -$3,108 | |
| 2023-09-26 | 2023-09-25 | RNAC | TRABER PETER G | Chief Medical Off | S - Sale | $1.06 | -705 | 451.8K | -0.2% | -$747.30 | |
| M | 2023-06-01 | 2023-05-30+ | RNAC | Kishimoto Takashi Kei | CSO | G - Gift | $0.00 | -139.0K | 251.8K | -36% | $0 |
| M | 2023-01-06 | 2023-01-04+ | RNAC | Johnston Lloyd P. | Chief Ops Off | S - Sale | $1.13 | -9,784 | 268.9K | -4% | -$11.1K |
| M | 2023-01-06 | 2023-01-04+ | RNAC | TRABER PETER G | Chief Medical Off | S - Sale | $1.13 | -11.6K | 446.1K | -3% | -$13.2K |
| M | 2023-01-06 | 2023-01-04+ | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.13 | -41.1K | 786.0K | -5% | -$46.4K |
| M | 2023-01-06 | 2023-01-04+ | RNAC | Kishimoto Takashi Kei | CSO | S - Sale | $1.13 | -9,784 | 364.3K | -3% | -$11.1K |
| D | 2023-01-04 | 2023-01-02 | RNAC | TRABER PETER G | Chief Medical Off | A - Grant | $0.00 | +200.0K | 457.8K | +78% | $0 |
| D | 2023-01-04 | 2023-01-02 | RNAC | Kishimoto Takashi Kei | CSO | A - Grant | $0.00 | +100.0K | 374.1K | +36% | $0 |
| D | 2023-01-04 | 2023-01-02 | RNAC | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +282.8K | 827.1K | +52% | $0 |
| D | 2023-01-04 | 2023-01-02 | RNAC | Johnston Lloyd P. | Chief Ops Off | A - Grant | $0.00 | +100.0K | 275.3K | +57% | $0 |
| 2022-12-07 | 2022-12-05 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.33 | -4,522 | 544.3K | -0.8% | -$6,014 | |
| D | 2022-12-05 | 2022-12-01 | RNAC | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 548.8K | +2% | $0 |
| 2022-09-30 | 2022-09-28 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.66 | -2,692 | 537.9K | -0.5% | -$4,469 | |
| D | 2022-09-06 | 2022-09-01 | RNAC | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 545.3K | +2% | $0 |
| D | 2022-09-06 | 2022-09-02 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale+OE | $1.85 | -4,768 | 540.6K | -0.9% | -$8,821 |
| 2022-06-15 | 2022-06-13 | RNAC | COX CARRIE SMITH | Dir | P - Purchase | $1.15 | +130.0K | 212.9K | +157% | +$149.5K | |
| D | 2022-06-03 | 2022-06-01 | RNAC | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 534.4K | +2% | $0 |
| 2022-05-11 | 2022-05-09 | RNAC | BARABE TIMOTHY C | Dir | P - Purchase | $0.77 | +50.0K | 250.0K | +25% | +$38.5K | |
| DI | 2022-04-13 | 2022-04-11 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | — | +6.68M | 29.87M | +29% | — |
| D | 2022-03-03 | 2022-03-01 | RNAC | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 528.9K | +2% | $0 |
| D | 2022-03-03 | 2022-03-02 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale+OE | $1.81 | -5,443 | 523.5K | -1% | -$9,852 |
| D | 2022-01-18 | 2022-01-14 | RNAC | BARABE TIMOTHY C | Dir | M - OptEx | $2.10 | +10.0K | 200.0K | +5% | +$21.0K |
| 2022-01-07 | 2022-01-05 | RNAC | TRABER PETER G | Chief Medical Off | S - Sale | $3.09 | -3,226 | 251.4K | -1% | -$9,968 | |
| 2022-01-07 | 2022-01-05 | RNAC | Johnston Lloyd P. | Chief Ops Off | S - Sale | $3.09 | -3,416 | 175.3K | -2% | -$10.6K | |
| 2022-01-07 | 2022-01-05 | RNAC | Kishimoto Takashi Kei | CSO | S - Sale | $3.09 | -3,416 | 268.4K | -1% | -$10.6K | |
| 2022-01-07 | 2022-01-05 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $3.09 | -13.6K | 518.0K | -3% | -$42.0K | |
| D | 2022-01-05 | 2022-01-03 | RNAC | Tan Kevin | CFO | A - Grant | $0.00 | +72.0K | 77.0K | +1,440% | $0 |
| D | 2022-01-05 | 2022-01-03 | RNAC | Kishimoto Takashi Kei | CSO | A - Grant | $0.00 | +72.0K | 271.8K | +36% | $0 |
| D | 2022-01-05 | 2022-01-03 | RNAC | Johnston Lloyd P. | Chief Ops Off | A - Grant | $0.00 | +72.0K | 178.7K | +67% | $0 |
| D | 2022-01-05 | 2022-01-03 | RNAC | TRABER PETER G | Chief Medical Off | A - Grant | $0.00 | +90.2K | 254.6K | +55% | $0 |
| D | 2022-01-05 | 2022-01-03 | RNAC | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +226.3K | 531.6K | +74% | $0 |
| I | 2021-12-17 | 2021-12-15 | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $2.99 | +211.2K | 23.19M | +0.9% | +$631.5K |
| 2021-12-14 | 2021-12-10 | RNAC | Johnston Lloyd P. | Chief Ops Off | S - Sale | $2.99 | -4,370 | 106.7K | -4% | -$13.1K | |
| 2021-12-14 | 2021-12-10 | RNAC | TRABER PETER G | Chief Medical Off | S - Sale | $2.99 | -4,083 | 164.4K | -2% | -$12.2K | |
| 2021-12-14 | 2021-12-10 | RNAC | Kishimoto Takashi Kei | CSO | S - Sale | $2.99 | -4,370 | 199.8K | -2% | -$13.1K | |
| 2021-12-14 | 2021-12-10 | RNAC | Pres, CEO, Dir | S - Sale | $2.99 | -17.2K | 305.3K | -5% | -$51.4K | ||
| MI | 2021-12-13 | 2021-12-09+ | RNAC | SPRINGER TIMOTHY A | Dir, 10% | P - Purchase | $3.06 | +3.82M | 22.98M | +20% | +$11.69M |
| 2021-12-10 | 2021-12-08 | RNAC | Johnston Lloyd P. | Chief Ops Off | A - Grant | $0.00 | +13.8K | 111.1K | +14% | $0 | |
| 2021-12-10 | 2021-12-08 | RNAC | Kishimoto Takashi Kei | CSO | A - Grant | $0.00 | +13.8K | 204.1K | +7% | $0 | |
| 2021-12-10 | 2021-12-08 | RNAC | TRABER PETER G | Chief Medical Off | A - Grant | $0.00 | +13.8K | 168.5K | +9% | $0 | |
| 2021-12-10 | 2021-12-08 | RNAC | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +37.5K | 322.5K | +13% | $0 | |
| 2021-12-06 | 2021-12-02 | RNAC | DeSilva Nishan M | Dir | P - Purchase | $2.96 | +7,000 | 7,000 | New | +$20.7K | |
| 2021-12-06 | 2021-12-03 | RNAC | COX CARRIE SMITH | Dir | P - Purchase | $2.95 | +17.2K | 82.9K | +26% | +$50.7K | |
| 2021-12-06 | 2021-12-02 | RNAC | Tan Kevin | CFO | P - Purchase | $3.03 | +5,000 | 5,000 | New | +$15.1K | |
| D | 2021-12-03 | 2021-12-01 | RNAC | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 289.7K | +4% | $0 |
| D | 2021-12-03 | 2021-12-02 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale+OE | $2.96 | -4,746 | 285.0K | -2% | -$14.0K |
| 2021-10-15 | 2021-10-13 | RNAC | TRABER PETER G | Chief Medical Off | S - Sale | $4.39 | -3,636 | 154.7K | -2% | -$16.0K | |
| 2021-10-15 | 2021-10-13 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $4.39 | -15.3K | 278.8K | -5% | -$67.2K | |
| 2021-10-15 | 2021-10-13 | RNAC | Kishimoto Takashi Kei | CSO | S - Sale | $4.39 | -3,892 | 190.4K | -2% | -$17.1K | |
| 2021-10-15 | 2021-10-13 | RNAC | Johnston Lloyd P. | Chief Ops Off | S - Sale | $4.39 | -3,892 | 97.3K | -4% | -$17.1K | |
| 2021-10-05 | 2021-10-01 | RNAC | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +37.5K | 294.1K | +15% | $0 | |
| 2021-10-05 | 2021-10-01 | RNAC | Kishimoto Takashi Kei | CSO | A - Grant | $0.00 | +13.8K | 194.3K | +8% | $0 | |
| 2021-10-05 | 2021-10-01 | RNAC | TRABER PETER G | Chief Medical Off | A - Grant | $0.00 | +13.8K | 158.3K | +10% | $0 | |
| 2021-10-05 | 2021-10-01 | RNAC | Johnston Lloyd P. | Chief Ops Off | A - Grant | $0.00 | +13.8K | 101.2K | +16% | $0 | |
| D | 2021-09-28 | 2021-09-24 | RNAC | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +27.2K | 256.6K | +12% | $0 |
| D | 2021-09-28 | 2021-09-24 | RNAC | TRABER PETER G | Chief Medical Off | A - Grant | $0.00 | +9,100 | 144.6K | +7% | $0 |
| D | 2021-09-03 | 2021-09-02 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale+OE | $4.51 | -4,523 | 229.4K | -2% | -$20.4K |
| D | 2021-09-03 | 2021-09-01 | RNAC | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 233.9K | +5% | $0 |
| 2021-08-20 | 2021-08-18 | RNAC | BARABE TIMOTHY C | Dir | P - Purchase | $4.00 | +9,000 | 190.0K | +5% | +$36.0K |
Purchase Sale Sale after option exercise All abbreviations